FBIO Stock Analysis: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$2.76
-0.37 (-11.82%)
▼
5d:
-15.6%
30d:
-9.21%
90d:
+18.45%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: FBIO is down 15.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: FBIO is down 15.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $2.76, which is considered oversold relative to its 30-day fair value range of $2.98 to $3.49. From a valuation perspective, the stock is trading at a discount (Forward PE: -5.5) compared to its historical average (136.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, FBIO is in a uptrend. Immediate support is located at $2.62, while resistance sits at $3.65. Short-term momentum is weak, with the stock down 11.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+298.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FBIO is in a uptrend. Immediate support is located at $2.62, while resistance sits at $3.65. Short-term momentum is weak, with the stock down 11.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+298.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.98 -
$3.49
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.8%)
- BULLISH: Trading 298.6% below Wall St target ($11.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to -15.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.98 -
$3.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.62
Resistance Level
$3.65
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.52
Wall Street Target
$11.00
(+298.6%)
Revenue Growth (YoY)
22.1%
Profit Margin
193.1%
PE vs Historical
-5.5 vs 136.2
CHEAP
Share & Embed Analysis
Last updated: August 03, 2026 10:19 PM ET
Data refreshes hourly during market hours. Next update: 11:19 PM
Data refreshes hourly during market hours. Next update: 11:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 54 HOLD |
